Current NDC auxiliary source row compounder:421

This page is keyed by dataset, FDA.report source record ID, and physical source row number. Empty values are shown rather than omitted.

Complete normalized row#

Record Source: ndc_compounder_zip
Product Ndc Raw: 26436-5483
Product Ndc: 26436-5483
Product Ndc Digits: 264365483
Product Type Name: HUMAN COMPOUNDED DRUG
Proprietary Name: ACH
Proprietary Name Suffix: [empty]
Nonproprietary Name: Ampotericin/ Chloramphenicol/ HC
Dosage Form Name: POWDER
Route Name: AURICULAR (OTIC)
Marketing Category Name: OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
Labeler Name: Hybrid Pharma
Establishment Name: Hybrid Pharma
Establishment Fei: [empty]
Substance Name: HYDROCORTISONE; AMPHOTERICIN B; CHLORAMPHENICOL
Active Ingredients Info: 10 mg/1 g; 50 mg/1 g; 500 mg/1 g
History Active Ingredients Raw: HYDROCORTISONE; AMPHOTERICIN B; CHLORAMPHENICOL
History Active Ingredients Info Raw: 10 mg/1 g; 50 mg/1 g; 500 mg/1 g
History Dosage Raw: POWDER
Dea Schedule: [empty]
Package Ndc Raw: 26436-5483-1
Package Ndc: 26436-5483-1
Package Ndc Digits: 2643654831
Package Ndc11: 26436548301
Package Description: 10 g in 1 JAR (26436-5483-1)
Reporting Period Raw: 2025-2
Reporting Period: 2025-2
Normalization Status: valid
Source Url: https://www.accessdata.fda.gov/cder/compounders_ndc_directory.zip
Source Archive: compounders_ndc_directory.zip
Source File: compounders_ndc_directory.txt
Source Date: 2026-09-18
Source Last Modified: Fri, 18 Sep 2026 15:17:23 GMT
Source Archive Sha256: 222f6800f79cb1a0fa79431b7226bd6b34899999dbf086af51004a96774ada98
Source Member Sha256: f8d9743e5616579a34d614887e86a53913efa0a63d3138d59d2f87cbb4d0cc17
Source Record Id: compounder:421
Source Row Number: 421
Source Row Hash: 66dbaae4aa8ac396f50836ba9fafd7537b2512a0609ff6ced42c7fb250d7cb65
Import Run Id: 20261015T162751Z
Loaded At: 2026-10-15 16:32:20

Exact raw FDA source fields#

{
    "ROUTENAME": "AURICULAR (OTIC)",
    "PRODUCTNDC": "26436-5483",
    "DEASCHEDULE": "",
    "LABELERNAME": "Hybrid Pharma",
    "SUBSTANCENAME": "HYDROCORTISONE; AMPHOTERICIN B; CHLORAMPHENICOL",
    "DOSAGEFORMNAME": "POWDER",
    "NDCPACKAGECODE": "26436-5483-1",
    "PRODUCTTYPENAME": "HUMAN COMPOUNDED DRUG",
    "PROPRIETARYNAME": "ACH",
    "REPORTINGPERIOD": "2025-2",
    "NONPROPRIETARYNAME": "Ampotericin/ Chloramphenicol/ HC",
    "PACKAGEDESCRIPTION": "10 g in 1 JAR (26436-5483-1) ",
    "ACTIVEINGREDIENTSINFO": "10 mg/1 g; 50 mg/1 g; 500 mg/1 g",
    "MARKETINGCATEGORYNAME": "OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)",
    "PROPRIETARYNAMESUFFIX": ""
}

Normalization notes#

[]

Current status projection#

Dataset: compounder
Record Source: ndc_compounder_zip
Source Record Id: compounder:421
Source Row Number: 421
Status Scope: package
Lookup Ndc: 26436-5483-1
Lookup Ndc Digits: 2643654831
Product Ndc: 26436-5483
Product Ndc Digits: 264365483
Package Ndc: 26436-5483-1
Package Ndc Digits: 2643654831
Package Ndc11: 26436548301
Product Id: [empty]
Status Code: COMPOUNDER
Status Label: Outsourcing facility compounded drug report
Reporting Period Raw: 2025-2
Reporting Period: 2025-2
Source Table: fda_ndc_aux_compounder
Source File: compounders_ndc_directory.txt
Source Date: 2026-09-18
Source Row Hash: 66dbaae4aa8ac396f50836ba9fafd7537b2512a0609ff6ced42c7fb250d7cb65
Import Run Id: 20261015T162751Z
Loaded At: 2026-10-15 16:32:20